New Medicare policies are bringing down costs for some patients
For years, American patients have suffered under a drug-pricing system that provides generous incentives for innovation, while too often failing to deliver important medications at an affordable cost. The flaws in America’s drug markets have been a topic of discussion in healthcare policy circles for years, but no comprehensive approach to reform has ever been undertaken. …
United States Representative, New Jersey, Democrat
Read MoreUnited States Representative, Massachussetts, Democrat
Read MoreFred Riccardi, President
Read MoreRussell Vought, Director
Read MoreUnited States Representative, Oregon, Republican
Read MoreUnited States Representative, Texas, Republican
Read MoreWhy are prices rising, and what can the government do about it?
Read MoreWould the U.S. be better off with a European-style pricing system?
Read MoreNew Medicare policies are bringing down costs for some patients
Read MorePatients turn to alternative therapies or stop taking medications
Read MoreBarriers to bringing drugs in from abroad
Read MoreA priority for both parties, but no agreement on a solution
Read MoreA need for further study versus potential brain damage in children
Read MoreAthlete empowerment versus congressional overreach
Read MoreA need for further study versus potential brain damage in children
Read MoreAthlete empowerment versus congressional overreach
Read More©2024 By The Congressional Digest Corporation. All Rights Reserved.
